Whalegun
Home

Amneal Pharmaceuticals AMRX paid Tarplin, Downs & Young $60K for lobbying in Q2 2026 · Health Issues, Budget

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q2 2026
Stock
Amneal Pharmaceuticals AMRX
Client
Amneal Pharmaceuticals
Reported
26/07/16

Up 0.0% from last quarter

What else happened in Amneal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Amneal Pharmaceuticals's other lobbying reports

Amneal Pharmaceuticals AMRX paid Tarplin, Downs & Young $60K for lobbying in Q2 2026 · Health Issues, Budget | Whalegun